Literature DB >> 26920880

Innate host defenses against Cryptococcus neoformans.

Camaron Hole1,2, Floyd L Wormley3,4.   

Abstract

Cryptococcus neoformans, the predominant etiological agent of cryptococcosis, can cause life-threatening infections of the central nervous system in immunocompromised and immunocompetent individuals. Cryptococcal meningoencephalitis is the most common disseminated fungal infection in AIDS patients, and remains the third most common invasive fungal infection among organ transplant recipients. The administration of highly active antiretroviral therapy (HAART) has resulted in a decrease in the number of cases of AIDS-related cryptococcosis in developed countries, but in developing countries where HAART is not readily available, Cryptococcus is still a major concern. Therefore, there is an urgent need for the development of novel therapies and/or vaccines to combat cryptococcosis. Understanding the protective immune responses against Cryptococcus is critical for development of vaccines and immunotherapies to combat cryptococcosis. Consequently, this review focuses on our current knowledge of protective immune responses to C. neoformans, with an emphasis on innate immune responses.

Entities:  

Keywords:  Cryptococcus; Cryptococcus neoformans; fungal immunity; fungal pathogenesis; host-fungal interactions

Mesh:

Substances:

Year:  2016        PMID: 26920880     DOI: 10.1007/s12275-016-5625-7

Source DB:  PubMed          Journal:  J Microbiol        ISSN: 1225-8873            Impact factor:   3.422


  115 in total

1.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.

Authors:  Erin E McClelland; André M Nicola; Rafael Prados-Rosales; Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

2.  Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.

Authors:  Donatella Pietrella; Cristina Corbucci; Stefano Perito; Giovanni Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  The clinical spectrum of pulmonary aspergillosis.

Authors:  Chris Kosmidis; David W Denning
Journal:  Thorax       Date:  2014-10-29       Impact factor: 9.139

4.  Pulmonary cryptococcosis in non-AIDS patients.

Authors:  Benquan Wu; Hui Liu; Jing Huang; Wenxian Zhang; Tiantuo Zhang
Journal:  Clin Invest Med       Date:  2009-02-01       Impact factor: 0.825

5.  Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung.

Authors:  John J Osterholzer; Rishi Surana; Jami E Milam; Gerald T Montano; Gwo-Hsiao Chen; Joanne Sonstein; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

6.  Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.

Authors:  Sarah E Hardison; Gina Herrera; Mattie L Young; Camaron R Hole; Karen L Wozniak; Floyd L Wormley
Journal:  J Immunol       Date:  2012-09-14       Impact factor: 5.422

7.  The presence of capsule in Cryptococcus neoformans influences the gene expression profile in dendritic cells during interaction with the fungus.

Authors:  P Lupo; Y C Chang; B L Kelsall; J M Farber; D Pietrella; A Vecchiarelli; F Leon; K J Kwon-Chung
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

8.  Cryptococcus neoformans modulates extracellular killing by neutrophils.

Authors:  Asfia Qureshi; Angus Grey; Kristie L Rose; Kevin L Schey; Maurizio Del Poeta
Journal:  Front Microbiol       Date:  2011-09-21       Impact factor: 5.640

9.  X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.

Authors:  Wendy A Szymczak; Michael J Davis; Steven K Lundy; Chad Dufaud; Michal Olszewski; Liise-anne Pirofski
Journal:  MBio       Date:  2013-07-02       Impact factor: 7.867

Review 10.  Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin.

Authors:  Judith E Allen; Tara E Sutherland
Journal:  Semin Immunol       Date:  2014-07-11       Impact factor: 11.130

View more
  12 in total

1.  The Major Surface Glycoprotein of Pneumocystis murina Does Not Activate Dendritic Cells.

Authors:  Monica Sassi; Geetha Kutty; Gabriela A Ferreyra; Lisa R Bishop; Yueqin Liu; Ju Qiu; Da Wei Huang; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2018-10-05       Impact factor: 5.226

2.  Human fungal pathogens: Why should we learn?

Authors:  Jeong-Yoon Kim
Journal:  J Microbiol       Date:  2016-03       Impact factor: 3.422

Review 3.  Role of microglia in fungal infections of the central nervous system.

Authors:  George W Koutsouras; Raddy L Ramos; Luis R Martinez
Journal:  Virulence       Date:  2016-11-18       Impact factor: 5.882

4.  Scavenger Receptor MARCO Orchestrates Early Defenses and Contributes to Fungal Containment during Cryptococcal Infection.

Authors:  Jintao Xu; Adam Flaczyk; Lori M Neal; Zhenzong Fa; Alison J Eastman; Antoni N Malachowski; Daphne Cheng; Bethany B Moore; Jeffrey L Curtis; John J Osterholzer; Michal A Olszewski
Journal:  J Immunol       Date:  2017-03-15       Impact factor: 5.422

Review 5.  Activation strategies for invariant natural killer T cells.

Authors:  Ayano C Kohlgruber; Carlos A Donado; Nelson M LaMarche; Michael B Brenner; Patrick J Brennan
Journal:  Immunogenetics       Date:  2016-07-25       Impact factor: 2.846

Review 6.  Transcriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species Comparison.

Authors:  Pedro Pais; Catarina Costa; Mafalda Cavalheiro; Daniela Romão; Miguel C Teixeira
Journal:  Front Cell Infect Microbiol       Date:  2016-10-20       Impact factor: 5.293

7.  Contribution of IL-1RI Signaling to Protection against Cryptococcus neoformans 52D in a Mouse Model of Infection.

Authors:  Mitra Shourian; Ben Ralph; Isabelle Angers; Donald C Sheppard; Salman T Qureshi
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

8.  Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection.

Authors:  Althea Campuzano; Natalia Castro-Lopez; Karen L Wozniak; Chrissy M Leopold Wager; Floyd L Wormley
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

Review 9.  Neuro-Immune Mechanisms of Anti-Cryptococcal Protection.

Authors:  Rebecca A Drummond
Journal:  J Fungi (Basel)       Date:  2017-12-25

10.  Extent of Lung Involvement and Serum Cryptococcal Antigen Test in Non-Human Immunodeficiency Virus Adult Patients with Pulmonary Cryptococcosis.

Authors:  Tao Zhu; Wan-Ting Luo; Gui-Hua Chen; Yue-Sheng Tu; Shuo Tang; Huo-Jin Deng; Wei Xu; Wei Zhang; Di Qi; Dao-Xin Wang; Chang-Yi Li; He Li; Yan-Qiao Wu; Shen-Jin Li
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.